Abstract: The present invention relates to a group of cannabinoid derivatives as pharmaceutically active compounds and methods of preparation thereof. The cannabinoid derivatives of the invention are analogues of cannabidiol (CBD). CBD is a non-psychoactive cannabinoid which has been used to treat various diseases and disorders.

Abstract: Devices, systems and methods are disclosed which relate to providing wing designs with payload integration capabilities on existing modularly assembled unmanned aerial vehicles (UAVs). Exemplary embodiments of the present invention present a novel technique of adding payloads to existing UAVs while improving flight performance over existing techniques by maintaining a similar overall weight with improved aerodynamic properties. The technique includes using a reinforced foam core center wing with a fiberglass epoxy skin. A lightweight payload canopy cover integrates onto the center wing as an agnostic enclosure for payloads. The payload canopy cover may contain venting holes for the cooling of electronic payloads. The systems may also include common devices such as antennas, GPS, and batteries for use with a wide range of payloads.

Abstract: Devices, systems and methods are disclosed which relate to providing wing designs with payload integration capabilities on existing modularly assembled unmanned aerial vehicles (UAVs). Exemplary embodiments of the present invention present a novel technique of adding payloads to existing UAVs while improving flight performance over existing techniques by maintaining a similar overall weight with improved aerodynamic properties. The technique includes using a reinforced foam core center wing with a fiberglass epoxy skin. A lightweight payload canopy cover integrates onto the center wing as an agnostic enclosure for payloads. The payload canopy cover may contain venting holes for the cooling of electronic payloads. The systems may also include common devices such as antennas, GPS, and batteries for use with a wide range of payloads.

Abstract: An agent for use in medicine, which agent comprises a plurality of ligands covalently co-linked so as to form a complex with a plurality of C-reactive protein (CRP) molecules in the presence thereof, wherein (i) at least two of the ligands are the same or different and are capable of being bound by ligand binding sites present on the CRP molecules; or (ii) at least one of the ligands is capable of being bound by a ligand binding site present on a CRP molecule, and at least one other of the ligands is capable of being bound by a ligand binding site present on a serum amyloid P component (SAP) molecule.